These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 16508404
1. Levosimendan, a new inotropic and vasodilator agent. Toller WG, Stranz C. Anesthesiology; 2006 Mar; 104(3):556-69. PubMed ID: 16508404 [Abstract] [Full Text] [Related]
4. Levosimendan: beyond its simple inotropic effect in heart failure. Antoniades C, Tousoulis D, Koumallos N, Marinou K, Stefanadis C. Pharmacol Ther; 2007 May 28; 114(2):184-97. PubMed ID: 17363065 [Abstract] [Full Text] [Related]
5. Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects. Pathak A, Lebrin M, Vaccaro A, Senard JM, Despas F. J Clin Pharm Ther; 2013 Oct 28; 38(5):341-9. PubMed ID: 23594161 [Abstract] [Full Text] [Related]
6. Troponin C-mediated calcium sensitization by levosimendan accelerates the proportional development of isometric tension. Haikala H, Levijoki J, Lindén IB. J Mol Cell Cardiol; 1995 Oct 28; 27(10):2155-65. PubMed ID: 8576932 [Abstract] [Full Text] [Related]
7. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure. Cavusoglu Y. Expert Opin Pharmacother; 2007 Apr 28; 8(5):665-77. PubMed ID: 17376021 [Abstract] [Full Text] [Related]
8. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure. Kivikko M, Lehtonen L. Curr Pharm Des; 2005 Apr 28; 11(4):435-55. PubMed ID: 15725064 [Abstract] [Full Text] [Related]
9. Levosimendan, a new calcium-sensitizing inotrope for heart failure. Ng TM. Pharmacotherapy; 2004 Oct 28; 24(10):1366-84. PubMed ID: 15628834 [Abstract] [Full Text] [Related]
10. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization. Bowman P, Haikala H, Paul RJ. J Pharmacol Exp Ther; 1999 Jan 28; 288(1):316-25. PubMed ID: 9862786 [Abstract] [Full Text] [Related]
11. Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition. Kaheinen P, Pollesello P, Hertelendi Z, Borbély A, Szilágyi S, Nissinen E, Haikala H, Papp Z. Basic Clin Pharmacol Toxicol; 2006 Jan 28; 98(1):74-8. PubMed ID: 16433895 [Abstract] [Full Text] [Related]
12. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit. Sato S, Talukder MA, Sugawara H, Sawada H, Endoh M. J Mol Cell Cardiol; 1998 Jun 28; 30(6):1115-28. PubMed ID: 9689586 [Abstract] [Full Text] [Related]
20. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H. Circulation; 1998 Nov 17; 98(20):2141-7. PubMed ID: 9815868 [Abstract] [Full Text] [Related] Page: [Next] [New Search]